Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.78
+0.0800 (+1.70%)
At Close: May 09, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.28 $5.69 Thursday, 9th May 2024 MBRX stock ended at $4.78. This is 1.70% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 9.54% from a day low at $4.61 to a day high of $5.05.
90 days $0.400 $6.23
52 weeks $0.338 $6.23

Historical Moleculin Biotech Inc prices

Date Open High Low Close Volume
Oct 04, 2023 $0.406 $0.454 $0.406 $0.430 68 075
Oct 03, 2023 $0.420 $0.435 $0.411 $0.412 19 160
Oct 02, 2023 $0.438 $0.438 $0.409 $0.437 58 503
Sep 29, 2023 $0.425 $0.439 $0.408 $0.428 52 102
Sep 28, 2023 $0.430 $0.440 $0.420 $0.423 51 799
Sep 27, 2023 $0.440 $0.440 $0.405 $0.405 46 989
Sep 26, 2023 $0.420 $0.439 $0.407 $0.420 67 532
Sep 25, 2023 $0.400 $0.430 $0.385 $0.409 156 978
Sep 22, 2023 $0.430 $0.430 $0.376 $0.390 59 978
Sep 21, 2023 $0.382 $0.420 $0.375 $0.420 126 675
Sep 20, 2023 $0.399 $0.400 $0.380 $0.382 25 517
Sep 19, 2023 $0.374 $0.400 $0.374 $0.395 46 936
Sep 18, 2023 $0.397 $0.400 $0.368 $0.385 274 741
Sep 15, 2023 $0.380 $0.400 $0.380 $0.397 111 312
Sep 14, 2023 $0.400 $0.400 $0.370 $0.392 130 299
Sep 13, 2023 $0.410 $0.420 $0.400 $0.400 42 315
Sep 12, 2023 $0.440 $0.450 $0.400 $0.410 70 120
Sep 11, 2023 $0.435 $0.435 $0.396 $0.401 56 291
Sep 08, 2023 $0.391 $0.469 $0.391 $0.424 137 765
Sep 07, 2023 $0.520 $0.543 $0.338 $0.391 764 458
Sep 06, 2023 $0.562 $0.578 $0.520 $0.521 104 299
Sep 05, 2023 $0.558 $0.576 $0.550 $0.550 17 138
Sep 01, 2023 $0.588 $0.588 $0.552 $0.552 63 706
Aug 31, 2023 $0.565 $0.600 $0.551 $0.560 47 067
Aug 30, 2023 $0.560 $0.599 $0.560 $0.565 56 182
Click to get the best stock tips daily for free!

About Moleculin Biotech Inc

Moleculin Biotech Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066, which is in Phase I clinical trial fo... MBRX Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT